Is Sotolaxib currently included in the national medical insurance?

Sotorasib is an innovative targeted drug targeting the KRAS G12C mutation. It has been approved and used clinically internationally, but it has not yet been officially launched in my country, and therefore has not yet been included in the national medical insurance directory. Due to the lack of marketing and medical insurance coverage, domestic patients are temporarily unable to purchase Sotorasibu directly through regular hospitals or pharmacies, and must rely on other channels to obtain drugs. This limits patient accessibility to a certain extent and increases the cost burden of treatment.

In overseas markets, the original drug of sotorasibu has been put on the market, mainly including the European version and the Hong Kong version. The price of original research drugs is relatively high, usually tens of thousands of yuan per box. The specific price fluctuates according to different regions and channels. High drug costs have become an important problem faced by many patients, and some people have to look for more economical alternatives to relieve financial pressure.

It is worth noting that with the increasing global demand for KRAS G12C targeted therapy, some overseas countries have launched generic drugs of sotoraxib. For example, the current market price of generic versions produced by Lao Lucius Pharmaceuticals and Lao Daxiong Pharmaceuticals has been significantly reduced. Taking the specification of 120mg*56 tablets as an example, the price is only more than 1,000 yuan. Compared with the original drug, it significantly reduces the cost of medication for patients and provides a new choice for patients with limited financial conditions.

Although generic drugs are affordable, patients still need to be cautious when choosing medications. Generally speaking, the ingredients and efficacy of formally produced generic drugs are basically the same as those of the original drugs, but there may be differences in production processes and quality control between different manufacturers. Therefore, it is recommended that patients purchase it through formal channels before using it and conduct treatment under the guidance of a professional doctor to ensure the safety and efficacy of the medication.

Reference materials:https://www.lumakras.com/